← Back to Search

Prescribed Detraining for Atrial Fibrillation (DAF Trial)

N/A

Waitlist Available

Led By James McKinney, MD

Research Sponsored by Cardiology Research UBC

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up taken at 0, 8, and 32 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial will test if reducing exercise for a few months can help athletes with a specific type of irregular heartbeat by using a device to monitor their heart rhythm. The goal is to see if this approach can prevent the irregular heartbeat from coming back and improve their quality of life.

Eligible Conditions

Atrial Fibrillation

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ taken at 0, 8, and 32 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~taken at 0, 8, and 32 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and taken at 0, 8, and 32 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Ratio of atrial fibrillation (AF) episodes

Symptomatic palpitations

Secondary study objectives

AF symptom severity

Atrial Fibrillation Effect on QualiTy-of-life (AFEQT) score

Electric Countershock

+4 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Prescribed DetrainingExperimental Treatment1 Intervention

Detraining period of 8-weeks which is defined as: 1. a 75% decrease in the amount of exercise (from baseline) 2. a 50% decrease in the intensity of exercise as measured in METS (from baseline) 3. Mitchell Classification classes 1A, 2A, 2B of activity are permitted

Group II: Continued Strenuous ExerciseActive Control1 Intervention

Continued strenuous athletics (no reduction in training volume) - athletes will be asked to document their activity and be fitted with an activity monitor during the run-in period and intervention period

Do I qualify?Apply below to find out